Roxbury Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$824K Buy
1,955
+7
+0.4% +$2.79K 0.63% 46
2026
Q2
$705K Buy
1,948
+5
+0.3% +$1.71K 0.56% 47
2026
Q1
$684K Buy
1,943
+28
+1% +$10K 0.61% 45
2025
Q4
$627K Sell
1,915
-5
-0.3% -$1.59K 0.56% 46
2025
Q3
$542K Sell
1,920
-234
-11% -$67.9K 0.5% 49
2025
Q2
$602K Buy
2,154
+188
+10% +$53.3K 0.59% 44
2025
Q1
$606K Sell
1,966
-55
-3% -$16.2K 0.59% 47
2024
Q4
$572K Buy
+2,021
New +$600K 0.55% 49

Other funds holding AMGN

Roxbury Financial's AMGN Position: Q3 2026 in Review

Roxbury Financial increased its Amgen (AMGN) stake by 0.36% in Q3 2026, buying an estimated $2.79K and bringing the position to 1,955 shares worth $824K. The position accounts for 0.63% of the portfolio, ranked #46.

Roxbury Financial first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Roxbury Financial held 1,955 shares of Amgen worth $824K as of Q3 2026.
  • Roxbury Financial bought 7 Amgen shares in Q3 2026, an estimated $2.79K.
  • Amgen made up 0.63% of Roxbury Financial's portfolio in Q3 2026, its #46 holding.
  • Roxbury Financial first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.